New prostate cancer treatment, SpaceOARĀ® Hydrogel, now available in the UK through GenesisCare / Augmenix UK Ltd. partnership

GenesisCare UK and Augmenix UK Ltd. announce a partnership to provide access to SpaceOAR Hydrogel, a minimally invasive hydrogel spacer, which lasts the duration of therapy and is proven to decrease unwanted side effects from radiotherapy treatment in patients with prostate cancer.
Pharmiweb